Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials.
作者信息
Schulz Martin, Bashirians George, Cheng Seng H, Levy Daniel I, Lundie Mark, Wilcox Lisa, Winburn Ian, Somanathan Suryanarayan
机构信息
Pfizer, 235 East 42 Street, New York, NY 10017, USA.
出版信息
Mol Ther Methods Clin Dev. 2023 Oct 11;31:101119. doi: 10.1016/j.omtm.2023.101119. eCollection 2023 Dec 14.
Abstract
摘要
Zotero 插件